Effect of hyperbaric oxygen therapy in experimental subcutaneous and pulmonary infections due to Pseudomonas aeruginosa

Undersea and Hyperbaric Medicine

Volumn 26, Issue 1, 1999, Pages 21-25

  Luongo, C ^a   Imperatore, F ^a   Matera, M G ^a   Mangoni, G ^a   Marmo, M ^a   Baroni, A ^a   Catalanotti, P ^a   Rossi, F ^a   Filippelli, A ^a  

^a NONE

Author keywords

Amikacin; Hyperbaric oxygen; Pseudomonas aeruginosa; Pulmonary and subcutaneous infections

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT;

ANIMAL; ARTICLE; BACTERIAL SKIN DISEASE; GRAM NEGATIVE INFECTION; HYPERBARIC OXYGEN; LUNG DISEASE; MALE; MICROBIOLOGY; MULTIMODALITY CANCER THERAPY; PSEUDOMONAS AERUGINOSA; RAT; WISTAR RAT;

AMIKACIN; ANIMALS; ANTI-BACTERIAL AGENTS; COMBINED MODALITY THERAPY; HYPERBARIC OXYGENATION; LUNG DISEASES; MALE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RATS; RATS, WISTAR; SKIN DISEASES, BACTERIAL;

EID: 0033093679     PISSN: 10662936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Goldman DA. Nosocomial infections control in United States of America. J Hosp Infect 1986; 8:116-128.
2. Landesperger WJ, Kelly-Wintenberg KD, Montie TC, et al. Inhibition of bacterial motility with human antifiaggellar monoclonal antibodies attenuates Pseudomonas aeruginosa-induced pneumonia in the immunocompetent rat. Infect Immnunol 1994; 62:4825-4830.
3. McGowan JE Jr. Changing etiology of nosocomial bacterremia and fungemia and other hospital-acquired infections. Rev Infect Dis 1985; 7: 357-370.
4. Garibaldi RA. Factor predisposing to bacteruria during indwelling urethral catheterization. N Engl J Med 1974; 291:215-219.
5. Denny FW, Clyde WA Jr. Acute lower respiratory tract infections in non-hospitalized children. J Pediatr 1986; 108:635-646.
6. Izawa K, Tsunoda T, Ura K, et al. Hyperbaric oxygen therapy in the treatment of refractory peripancreatic abscesses associated with severe acute pancreatitis. Gastrenterol Jpn 1993; 28:284-291.
7. Baroni GC, Porro T, Faglia E. Hyperbaric oxygen in diabetic gangrene treatment. Diabetes Care 1987; 10: 81-86.
8. Muhvich KH, Anderson LH, Mehm WJ. Evaluation of antimicrobials combined with hyperbaric oxygen in a mouse model of clostridial myonecrosis. J Trauma 1994; 36:710-714.
9. Sutheriand KR, Steinberg KP, Maunder RJ, Alien DL, Hudson LD. Pulmonary infection during the acute respiratory distress syndrome. Am J Respir Dis Crit Care Med 1995; 152:550-556.
10. Snedecor GW, Cochran WG. Statistical methods, 6th ed. Ames, IA: Iowa State University Press, 1976:549-561.
11. Marzella L, Vezzani G. Effect of hyperbaric oxygen on activity of antimicrobial agents. In: Oriani G, Marroni A, Wattel F, eds. Handbook on hyperbaric medicine. New York: Springer-Verlag, 1996: 699-713.
12. McCord JM, Keele BB Jr, Fridovich I. An enzyme-based theory of obligate anaerobiosis; the physiological function of superoxide-dismutase. Proc Natl Acad Sci USA 1981; 68:1024-1036.
13. Park MK, Muhvich KH, Meyers RA, Marzella L. Hypoxia prolongs the aminoglycosides-induced postantibiotic effects in Pseudomonas aeruginosa. Agents Chemother 1991; 35:691-695.